Table 2. Characteristics of 90Y-TARE treatment.
BSA | 1.9±0.3 (range 1.4–2.3) |
---|---|
Lung shunt study (%) | Median: 3 (1.4–6) |
Treatment target | |
Whole liver | 0 |
Right lobe | 5 (22%) |
Left lobe | 3 (13%) |
Segmental | 5 (22%) |
Multisegmental | 10 (43%) |
Targeted liver volume (ml) | 1056±484 (range: 297–1820) |
Targeted tumour volume (ml) | 180±163 (range: 7–572) |
Delivered activity (GBq) | 1.5±0.4 (range: 0.8–2.24) |
Length of hospitalisation (hours) | |
<24 | 0 |
24–72 | 18 (86%) |
>72 | 3 (14%) |
Abbreviation: BSA=body surface area.